Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Explore year-end ETF Tax-Loss Harvesting ideas to harvest losses before year-end, diversify replacements, and sharpen tax efficiency.
25,086 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Massive accumulation by large holders and dwindling exchange reserves are fueling debate over a possible Bitcoin bott...
Tech stocks just their footing as an AI spending surge loses steam. The sector faced a rough week, driven by slower d...
An emerging markets high dividend ETF is delivering a standout yield for income-focused investors, but the strategy c...
When a prominent executive questions a public pledge with a personal twist, investors and workers feel the reverberat...
Crypto funds see bitcoin potentially near a bottom as inflows return and risk appetite rekindles, signaling a potenti...
A timeless framework guides Buffett's choices: value, quality, and disciplined risk. This article breaks down Warren ...
Oil-driven volatility keeps the S&P 500 near unchanged on March 11, 2026, as traders weigh supply risks and central-b...
AGNC Investment's dividend yield may catch your eye, but a high number isn’t the whole story. This guide breaks down ...
As the chip index climbs, fund managers sit on a cautious chair, weighing gains against risk. Bank of America flags p...
Three tech giants moved in sync for the first time in years, powered by AI momentum. Here’s how to interpret the sign...
Salesforce surged Thursday as the company announced a major debt offering to back a sizable share repurchase plan. Th...